27 January 2026

Menopause is linked to reductions in grey matter volume in key brain regions as well as increased levels of anxiety and depression and difficulties with sleep, according to new research from the University of Cambridge.

The study, supported by Cambridge BRC and published today in Psychological Medicine, found that hormone replacement therapy (HRT) does not appear to mitigate these effects, though it can slow the decline in reaction times.

Menopause is a key period in a woman’s life when her periods stop, due to lower hormone levels. It typically affects women between the ages of 45 and 55, during which time they may experience hot flushes, low mood and sleep problems. Menopause has previously been linked to cognitive decline, such as memory, attention and language deficits.

To counter the effects of menopause – particularly depressive symptoms and sleep problems – many women are prescribed HRT. In England, in 2023, 15% of women were prescribed the treatment. However, there is limited understanding of the effects of menopause and subsequent HRT use on the brain, cognition and mental health.

To address this question, researchers at the University of Cambridge analysed data from the UK Biobank of almost 125,000 women, who were classified into three categories: pre-menopause, post-menopause who have never used HRT, or post-menopause who have used HRT.

As well as answering questionnaires that included questions related to their experience of menopause, self-reported mental health, sleep patterns and overall health, some participants took part in tests of cognition, including tests of memory and reaction times. Around 11,000 participants also underwent magnetic resonance imaging (MRI) scans, allowing the researchers to look at the structure of their brains.

The average age of onset of menopause among the participants was around 49.5 years, while the average age that women prescribed HRT began their treatment was around 49 years.

Post-menopausal women were more likely than those pre-menopause to have sought help from their GP or a psychiatrist for anxiety, nerves or depression, and to score more highly on questionnaires for symptoms of depression. Similarly, they were more likely to have been prescribed antidepressants.

Although women in the HRT group had greater anxiety and depression compared with the non-HRT group, further analysis showed that these differences in symptoms were already present before menopause. It is possible, say the researchers, that in some cases, a woman’s GP may have prescribed HRT in anticipation of menopause worsening her symptoms.

Women post-menopause were more likely to report insomnia, get less sleep, and feel tired. Those on HRT reported feeling the most tired of all three groups, even though there was no difference in sleep duration between these women and those women post-menopause not on the medication.

Professor Barbara Sahakian, pictured below, the study’s senior author from the Department of Psychiatry, and a researcher at the NIHR Cambridge Biomedical Research Centre, said: “Most women will go through menopause, and it can be a life-changing event, whether they take HRT or not. A healthy lifestyle – exercising, keeping active and eating a healthy diet, for example – is particularly important during this period to help mitigate some of its effects.